it has brought infringement proceedings against the respondent deltapine australia pty ltd (deltapine).
deltapine says they should be conducted in australia.
bayer alleges that deltapine's exploitation of its bollgard ii variety of cotton, which contains bt icp genes coding for cry1ac and cry2ab toxins, infringes certain claims of the patent.